Aquestive Therapeutics Stock Analysis

Aquestive Stock Analysis Notes

About 48.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.51. Aquestive Therapeutics had not issued any dividends in recent years. Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey. Aquestive Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 157 people. For more info on Aquestive Therapeutics please contact Keith Kendall at 908 941 1900 or go to https://www.aquestive.com.

Aquestive Therapeutics Investment Alerts

Aquestive Therapeutics Upcoming and Recent Events

Aquestive Largest EPS Surprises

View All Earnings Estimates

Aquestive Therapeutics Environmental, Social, and Governance (ESG) Scores

Aquestive Therapeutics Thematic Classifications

Aquestive Stock Institutional Investors

Note, although Aquestive Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Aquestive Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 318.37 M.

Aquestive Profitablity

The company has Profit Margin (PM) of (0.77) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.14.

Management Efficiency

Aquestive Therapeutics has return on total asset (ROA) of (0.2422) % which means that it has lost $0.2422 on every $100 spent on assets. This is way below average. Aquestive Therapeutics' management efficiency ratios could be used to measure how well Aquestive Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 0.93 in 2025, whereas Return On Tangible Assets are likely to drop (0.46) in 2025. Total Current Liabilities is likely to gain to about 20.1 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 71.8 M in 2025.

Technical Drivers

As of the 26th of March, Aquestive Therapeutics shows the Mean Deviation of 3.3, standard deviation of 4.35, and Risk Adjusted Performance of (0.03). Aquestive Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Aquestive Therapeutics Price Movement Analysis

Aquestive Therapeutics Insider Trading Activities

Aquestive Therapeutics Outstanding Bonds

Aquestive Therapeutics Predictive Daily Indicators

Aquestive Therapeutics Corporate Filings

Aquestive Therapeutics Forecast Models

Aquestive Therapeutics' time-series forecasting models are one of many Aquestive Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aquestive Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Aquestive Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aquestive shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Aquestive Therapeutics. By using and applying Aquestive Stock analysis, traders can create a robust methodology for identifying Aquestive entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aquestive analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aquestive analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Aquestive Therapeutics stock analysis indicators help investors evaluate how Aquestive Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Aquestive Therapeutics shares will generate the highest return on investment. By understating and applying Aquestive Therapeutics stock analysis, traders can identify Aquestive Therapeutics position entry and exit signals to maximize returns.

When running Aquestive Therapeutics' price analysis, check to measure Aquestive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aquestive Therapeutics is operating at the current time. Most of Aquestive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aquestive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aquestive Therapeutics' price. Additionally, you may evaluate how the addition of Aquestive Therapeutics to your portfolios can decrease your overall portfolio volatility.